{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "30557503", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "07", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.1021/acs.joc.8b02390"], "Journal": {"ISSN": "1520-6904", "JournalIssue": {"Volume": "84", "Issue": "8", "PubDate": {"Year": "2019", "Month": "Apr", "Day": "19"}}, "Title": "The Journal of organic chemistry", "ISOAbbreviation": "J Org Chem"}, "ArticleTitle": "Development of a Commercial Process To Prepare AMG 232 Using a Green Ozonolysis-Pinnick Tandem Transformation.", "Pagination": {"StartPage": "4763", "EndPage": "4779", "MedlinePgn": "4763-4779"}, "Abstract": {"AbstractText": ["A robust process to manufacture AMG 232 was developed to deliver drug substance of high purity. Highlights of the commercial process development efforts include the following: (i) use of a novel bench-stable Vilsmeier reagent, methoxymethylene- N, N-dimethyliminium methyl sulfate, for selective in situ activation of a primary alcohol intermediate; (ii) use of a new crystalline and stable isopropyl calcium sulfinate reagent ensuring robust preparation of a sulfone intermediate; (iii) development of a safe ozonolysis process conducted in an aqueous solvent mixture in either batch or continuous manufacturing mode; and (iv) control of the drug substance purity by crystallization of a salt rejecting impurities effectively. The new process was demonstrated to afford the drug substance (99.9 LC area %) in 49.8% overall yield from starting material DLAC (1)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Cochran", "ForeName": "Brian M", "Initials": "BM"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Corbett", "ForeName": "Michael T", "Initials": "MT"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Correll", "ForeName": "Tiffany L", "Initials": "TL"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": ["0000-0002-8952-1018"], "LastName": "Fang", "ForeName": "Yuan-Qing", "Initials": "YQ"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": ["0000-0001-7266-8999"], "LastName": "Flick", "ForeName": "Tawnya G", "Initials": "TG"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Jones", "ForeName": "Si\u00e2n C", "Initials": "SC"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": ["0000-0002-8429-9534"], "LastName": "Silva Elipe", "ForeName": "Maria V", "Initials": "MV"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Smith", "ForeName": "Austin G", "Initials": "AG"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Tucker", "ForeName": "John L", "Initials": "JL"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Vounatsos", "ForeName": "Filisaty", "Initials": "F"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Wells", "ForeName": "Greg", "Initials": "G"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Yeung", "ForeName": "David", "Initials": "D"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Walker", "ForeName": "Shawn D", "Initials": "SD"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": [], "LastName": "Bio", "ForeName": "Matthew M", "Initials": "MM"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Pivotal Drug Substance Technologies , Amgen Inc ., One Amgen Center Drive , Thousand Oaks , California 91320 , United States."}], "Identifier": ["0000-0001-5434-5483"], "LastName": "Caille", "ForeName": "Seb", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Org Chem", "NlmUniqueID": "2985193R", "ISSNLinking": "0022-3263"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Acetates"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidones"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "isolation & purification"], "DescriptorName": "Acetates"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemical synthesis", "chemistry", "isolation & purification"], "DescriptorName": "Piperidones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30557503", "10.1021/acs.joc.8b02390"]}}]}